Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check7 days agoChange DetectedThe revision tag for the page has been updated from v3.6.0 to v3.6.2, indicating a new version of the record history page.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe history now notes that recruitment is closed ('No longer looking for participants') and the revision tag has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check28 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 in the page history, signaling a new revision of the record. It represents a metadata version change rather than altering study data or content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a new release version in the history. This update does not change the underlying study content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 from the version history.SummaryDifference0.2%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.